Receive a FREE Mesothelioma Treatment
Information Packet

Mesothelioma

Phase II Pilot Study of Cyclophosphamide and Active Intralymphatic Immunotherapy

Phase II Pilot Study of Cyclophosphamide and Active Intralymphatic Immunotherapy With a Vaccine Containing Interferon alfa or Interferon gamma-Treated Tumor Cells Followed by Sargramostim (GM-CSF) in Patients With Advanced Cancers

Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Vaccines made from a patient's tumor tissue may make the body build an immune response to kill tumor cells. Chemotherapy combined with vaccine therapy may kill more tumor cells. This is a Phase II trial to study the effectiveness of cyclophosphamide plus tumor cell vaccine in treating patients who have metastatic cancer or cancer at high risk of recurrence.

Location/Contacts:
California
Los Angeles
St. Vincent Medical Center - Los Angeles
Charles L. Wiseman, MD, FACP, Protocal Chair
Ph: 213-484-7575